Delivery Order SPE2DB22D2211-SPE2DB24FRJNP

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $2,253.38 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor supporting the U.S. government. The contract has an ultimate completion date of May 23, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that is a subsidiary of Cencora, Inc. The contract has a ceiling value of $14,685.54 and an ultimate completion date of May 7, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to...
This federal contract award is for the delivery of Mounjaro 15 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a total ceiling value of $2,072.16. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. This appears to be a delivery order contract, with a firm fixed-price pricing type. The contract is not set aside for any...
This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens, a medical product used to treat various health conditions. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,893.00 and an ultimate completion date of September 22, 2023. It is a delivery order contract with a firm fixed-price pricing type. The...
This federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,578.00, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 1, 2023. The contract is a delivery order with a firm fixed price and has an ultimate completion date of June 2, 2023. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which...
This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a defense agency. The $6,818.99 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of September 4, 2024. This contract is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,111.27, is a Firm Fixed Price Delivery Order for the supply of Mounjaro 10 mg/0.5 ml pens. It has an ultimate completion date of July 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, for the delivery of Mounjaro 5 mg/0.5 ml pens. The contract has a firm fixed price of $3,156.00 and a period of performance through March 19, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to provide...
The federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pen (0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $2,630 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 5 mg/0.5 ml pens, a pharmaceutical product. The award has a ceiling value of $30,094.55 and an ultimate completion date of February 19, 2025. The contract is a delivery order with a firm fixed price pricing type. This award is not designated as a set-aside contract....
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FRJNP
    Delivery Order

This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $8,416.00, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of September 30, 2024 and is a firm fixed-price delivery order. No set-aside was used for this award. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, for providing a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare needs.

Generated 12/27/24, 9:10 AM